<h1>High-altitude probiotic plant claims oxygen-free production, many patents, exports - watch regulatory, safety, biosecurity, IP and benefit-sharing risks</h1> A biotechnology company announced commencement of operations at a high-altitude probiotic production facility, claiming oxygen-free manufacturing, dozens of plateau-derived strains, over 50 patent applications, and commercial shipments and distributor agreements. Legal issues to monitor include regulatory approvals for probiotic manufacture and marketing, product safety and labeling compliance, export/import controls on biological materials, biosecurity and bioethics related to sourcing from humans and wildlife, benefit-sharing or access-and-benefit obligations under biodiversity laws, intellectual property scope and freedom-to-operate, and labor and local community engagement commitments tied to employment and training claims.